Amkay Products Ltd

Amkay Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Amkay Products Ltd

₹ 45.0 -2.17%
21 May - close price
amkayproducts.com BSE - SME: 544169
About

Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products[1]

Key Points

Business Overview:[1][2]
APL manufactures medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, Surgeon cap etc. These are used by healthcare centres, hospitals, nursing homes etc., under the brand name Amkay.
APL is the largest manufacturer of Blood Lancet Needles - Steel/Plastic in India. They have 50+ SKUs and 1000+ Distributors

Website BSE
  • Market Cap ₹ 39.0 Cr.
  • Current Price ₹ 45.0
  • High / Low ₹ 89.0 / 36.0
  • Stock P/E 12.3
  • Book Value ₹ 26.1
  • Dividend Yield 0.00 %
  • ROCE 22.4 %
  • ROE 22.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Earnings include an other income of Rs.1.49 Cr.
  • Working capital days have increased from 69.0 days to 105 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Mar 2024 Sep 2024
14.37 16.69 17.84
12.58 15.15 15.45
Operating Profit 1.79 1.54 2.39
OPM % 12.46% 9.23% 13.40%
0.48 0.76 0.73
Interest 0.24 0.28 0.18
Depreciation 0.26 0.30 0.34
Profit before tax 1.77 1.72 2.60
Tax % 26.55% 23.26% 30.00%
1.30 1.33 1.83
EPS in Rs 2.04 2.09 2.11
Raw PDF
Upcoming result date: tomorrow

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
26.41 40.63 36.47 27.86 31.07 34.53
24.82 36.14 33.78 24.93 27.74 30.60
Operating Profit 1.59 4.49 2.69 2.93 3.33 3.93
OPM % 6.02% 11.05% 7.38% 10.52% 10.72% 11.38%
0.04 0.10 0.29 0.46 1.25 1.49
Interest 0.47 0.24 0.41 0.47 0.52 0.46
Depreciation 0.52 0.51 0.54 0.69 0.56 0.64
Profit before tax 0.64 3.84 2.03 2.23 3.50 4.32
Tax % 25.00% 25.00% 28.08% 30.49% 24.86%
0.48 2.88 1.47 1.55 2.63 3.16
EPS in Rs 173.29 1,039.71 530.69 559.57 4.13 4.20
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -9%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -13%
TTM: 47%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -44%
Return on Equity
10 Years: %
5 Years: %
3 Years: 22%
Last Year: 22%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.28 0.28 0.28 0.28 6.36 8.66
Reserves 2.42 5.67 5.93 7.10 3.64 13.90
1.62 0.42 4.33 4.70 5.47 2.75
2.55 7.69 5.26 2.90 2.47 3.88
Total Liabilities 6.87 14.06 15.80 14.98 17.94 29.19
0.00 0.00 3.91 2.40 2.58 3.69
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.40 2.79 3.62 3.23 5.26
6.87 13.66 9.10 8.96 12.13 20.24
Total Assets 6.87 14.06 15.80 14.98 17.94 29.19

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.00 0.00 -0.25 0.01 -0.70
0.00 0.00 -3.07 -0.34 0.47
0.00 0.00 2.59 0.31 0.29
Net Cash Flow 0.00 0.00 -0.72 -0.01 0.06

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31.23 40.43 36.33 48.47 46.87
Inventory Days 4.54 4.18 28.03 46.61 92.57
Days Payable 41.76 82.57 64.42 44.46 33.99
Cash Conversion Cycle -5.98 -37.96 -0.06 50.62 105.45
Working Capital Days 10.78 -8.62 29.82 71.79 105.26
ROCE % 76.33% 28.86% 20.87% 22.36%

Shareholding Pattern

Numbers in percentages

1 Recently
May 2024Sep 2024Dec 2024Mar 2025
73.43% 73.43% 73.43% 73.44%
5.25% 0.16% 0.00% 0.00%
6.28% 0.00% 0.00% 0.00%
15.03% 26.41% 26.55% 26.56%
No. of Shareholders 621606593584

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports